ISA Saúde

Based in Brazil, ISA Saúde operates as a healthcare provider specializing in innovative home healthcare solutions that blend technology with personalized medical care. ISA Saúde, founded in 2019, is headquartered in São Paulo, Brazil, and focuses on delivering advanced home healthcare services. In October 2025, the company raised USD 30. 000 mn in a Series B funding round led by International Finance Corporation, with participation from various investors including Dalus Capital and Endeavor Catalyst.

This round marks the firm's first significant deal since its inception, supporting its growth in the healthcare sector. ISA Saúde specializes in providing comprehensive home healthcare services that integrate advanced technology with personalized clinical care. Their core offerings include full hospital-at-home services, intensive domiciliary care, palliative care, and specialized outpatient monitoring, all designed to ensure high-quality health management in the comfort of patients' homes. The company's services cater to a wide range of end-users, including patients recovering from surgeries, individuals with chronic conditions, and those requiring rehabilitative support, with an emphasis on delivering rapid, effective responses to avoid unnecessary hospital visits.

With coverage in major Brazilian regions such as São Paulo, Goiás, the Federal District, and Minas Gerais, ISA Saúde aims to expand its reach across the country, addressing the growing demand for accessible and humane healthcare solutions. ISA Saúde generates revenue through a structured service model that includes partnerships with health operators and direct-to-consumer transactions. The company utilizes subscription-based services for ongoing care, allowing for consistent revenue generation while ensuring patients receive regular health monitoring and support. Their flagship service offerings, such as full hospital-at-home care and specialized wound treatment, are tailored to meet specific patient needs, thus facilitating a diverse range of billing scenarios for both individual clients and healthcare providers.

The transactions typically involve direct billing for services rendered, with pricing plans structured to accommodate various healthcare requirements, ensuring that patients receive timely and effective care while maintaining financial transparency. In October 2025, ISA Saúde raised USD 30. 000 mn in a venture funding round led by International Finance Corporation (IFC), along with IDB Lab, Dalus Capital, and Endeavor Catalyst. The company will utilize the funding to expand into more cities across Brazil, strengthen B2B partnerships with leading health insurers, enhance its service portfolio, and leverage AI to improve patient experiences.

The strategic acquisitions are also planned to further solidify their market position.